BATS BZX Real-Time Price
As of 12:32pm ET
| +0.025 / +1.71%|
The 3 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 6.00 and a low estimate of 3.50. The median estimate represents a +169.36% increase from the last price of 1.49.
The current consensus among 6 polled investment analysts is to Buy stock in Arena Pharmaceuticals Inc. This rating has held steady since March, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.